These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

595 related items for PubMed ID: 25771452

  • 1. The profile of mephedrone on human monoamine transporters differs from 3,4-methylenedioxymethamphetamine primarily by lower potency at the vesicular monoamine transporter.
    Pifl C, Reither H, Hornykiewicz O.
    Eur J Pharmacol; 2015 May 15; 755():119-26. PubMed ID: 25771452
    [Abstract] [Full Text] [Related]

  • 2. MDMA (Ecstasy) and human dopamine, norepinephrine, and serotonin transporters: implications for MDMA-induced neurotoxicity and treatment.
    Verrico CD, Miller GM, Madras BK.
    Psychopharmacology (Berl); 2007 Jan 15; 189(4):489-503. PubMed ID: 16220332
    [Abstract] [Full Text] [Related]

  • 3. Pharmacological characterization of ecstasy synthesis byproducts with recombinant human monoamine transporters.
    Pifl C, Nagy G, Berényi S, Kattinger A, Reither H, Antus S.
    J Pharmacol Exp Ther; 2005 Jul 15; 314(1):346-54. PubMed ID: 15831439
    [Abstract] [Full Text] [Related]

  • 4. Comparison of the monoamine transporters from human and mouse in their sensitivities to psychostimulant drugs.
    Han DD, Gu HH.
    BMC Pharmacol; 2006 Mar 03; 6():6. PubMed ID: 16515684
    [Abstract] [Full Text] [Related]

  • 5. Substituted methcathinones differ in transporter and receptor interactions.
    Eshleman AJ, Wolfrum KM, Hatfield MG, Johnson RA, Murphy KV, Janowsky A.
    Biochem Pharmacol; 2013 Jun 15; 85(12):1803-15. PubMed ID: 23583454
    [Abstract] [Full Text] [Related]

  • 6. The psychostimulant (±)-cis-4,4'-dimethylaminorex (4,4'-DMAR) interacts with human plasmalemmal and vesicular monoamine transporters.
    Maier J, Mayer FP, Luethi D, Holy M, Jäntsch K, Reither H, Hirtler L, Hoener MC, Liechti ME, Pifl C, Brandt SD, Sitte HH.
    Neuropharmacology; 2018 Aug 15; 138():282-291. PubMed ID: 29908239
    [Abstract] [Full Text] [Related]

  • 7. 2-Aminoindan and its ring-substituted derivatives interact with plasma membrane monoamine transporters and α2-adrenergic receptors.
    Halberstadt AL, Brandt SD, Walther D, Baumann MH.
    Psychopharmacology (Berl); 2019 Mar 15; 236(3):989-999. PubMed ID: 30904940
    [Abstract] [Full Text] [Related]

  • 8. Interaction Profiles of Central Nervous System Active Drugs at Human Organic Cation Transporters 1-3 and Human Plasma Membrane Monoamine Transporter.
    Angenoorth TJF, Stankovic S, Niello M, Holy M, Brandt SD, Sitte HH, Maier J.
    Int J Mol Sci; 2021 Nov 30; 22(23):. PubMed ID: 34884800
    [Abstract] [Full Text] [Related]

  • 9. 3,4-Methylenedioxymethamphetamine, mephedrone, and β-phenylethylamine release dopamine from the cytoplasm by means of transporters and keep the concentration high and constant by blocking reuptake.
    Zsilla G, Hegyi DE, Baranyi M, Vizi ES.
    Eur J Pharmacol; 2018 Oct 15; 837():72-80. PubMed ID: 30172789
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Effects of 3,4-methylenedioxymethamphetamine (MDMA) on serotonin transporter and vesicular monoamine transporter 2 protein and gene expression in rats: implications for MDMA neurotoxicity.
    Biezonski DK, Meyer JS.
    J Neurochem; 2010 Feb 15; 112(4):951-62. PubMed ID: 20002520
    [Abstract] [Full Text] [Related]

  • 12. Pharmacological profile of mephedrone analogs and related new psychoactive substances.
    Luethi D, Kolaczynska KE, Docci L, Krähenbühl S, Hoener MC, Liechti ME.
    Neuropharmacology; 2018 May 15; 134(Pt A):4-12. PubMed ID: 28755886
    [Abstract] [Full Text] [Related]

  • 13. Ethylenedioxy homologs of N-methyl-(3,4-methylenedioxyphenyl)-2-aminopropane (MDMA) and its corresponding cathinone analog methylenedioxymethcathinone: Interactions with transporters for serotonin, dopamine, and norepinephrine.
    Del Bello F, Sakloth F, Partilla JS, Baumann MH, Glennon RA.
    Bioorg Med Chem; 2015 Sep 01; 23(17):5574-9. PubMed ID: 26233799
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Comparative potencies of 3,4-methylenedioxymethamphetamine (MDMA) analogues as inhibitors of [3H]noradrenaline and [3H]5-HT transport in mammalian cell lines.
    Montgomery T, Buon C, Eibauer S, Guiry PJ, Keenan AK, McBean GJ.
    Br J Pharmacol; 2007 Dec 01; 152(7):1121-30. PubMed ID: 17891159
    [Abstract] [Full Text] [Related]

  • 16. Methylenedioxymethamphetamine decreases plasmalemmal and vesicular dopamine transport: mechanisms and implications for neurotoxicity.
    Hansen JP, Riddle EL, Sandoval V, Brown JM, Gibb JW, Hanson GR, Fleckenstein AE.
    J Pharmacol Exp Ther; 2002 Mar 01; 300(3):1093-100. PubMed ID: 11861820
    [Abstract] [Full Text] [Related]

  • 17. The psychoactive aminoalkylbenzofuran derivatives, 5-APB and 6-APB, mimic the effects of 3,4-methylenedioxyamphetamine (MDA) on monoamine transmission in male rats.
    Brandt SD, Walters HM, Partilla JS, Blough BE, Kavanagh PV, Baumann MH.
    Psychopharmacology (Berl); 2020 Dec 01; 237(12):3703-3714. PubMed ID: 32875347
    [Abstract] [Full Text] [Related]

  • 18. "Polytox" synthetic cathinone abuse: A potential role for organic cation transporter 3 in combined cathinone-induced efflux.
    Mayer FP, Schmid D, Holy M, Daws LC, Sitte HH.
    Neurochem Int; 2019 Feb 01; 123():7-12. PubMed ID: 30248432
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Inhibitory effect of selective serotonin reuptake inhibitors on the vesicular monoamine transporter 2.
    Yasumoto S, Tamura K, Karasawa J, Hasegawa R, Ikeda K, Yamamoto T, Yamamoto H.
    Neurosci Lett; 2009 May 01; 454(3):229-32. PubMed ID: 19429089
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 30.